Anticancer drug candidate inhibits lethal aggregation of mutant tumor suppressor protein
Cancer is a multidisciplinary disease, with different mutations leading to different prognoses and treatment necessities. Among the most important mutation targets in cancers, affecting more than 50 percent of all cancer ...
Jan 15, 2019
0
1